| Isolation of high affinity human antibodies directly from large synthetic repertoires. AD Griffiths, SC Williams, O Hartley, IM Tomlinson, P Waterhouse, ... The EMBO journal 13 (14), 3245-3260, 1994 | 1441 | 1994 |
| Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases L Cartier, O Hartley, M Dubois-Dauphin, KH Krause Brain Research Reviews 48 (1), 16-42, 2005 | 633 | 2005 |
| Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 MM Lederman, RS Veazey, R Offord, DE Mosier, J Dufour, M Mefford, ... Science 306 (5695), 485-487, 2004 | 485 | 2004 |
| V3: HIV's switch-hitter O Hartley, PJ Klasse, QJ Sattentau, JP Moore AIDS Research & Human Retroviruses 21 (2), 171-189, 2005 | 412 | 2005 |
| Microbicides and other topical strategies to prevent vaginal transmission of HIV MM Lederman, RE Offord, O Hartley Nature Reviews Immunology 6 (5), 371-382, 2006 | 278 | 2006 |
| Characterization of events during the late stages of HPV16 infectionin vivousing high-affinity synthetic fabs to E4 J Doorbar, C Foo, N Coleman, L Medcalf, O Hartley, T Prospero, ... Virology 238 (1), 40-52, 1997 | 232 | 1997 |
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors O Hartley, H Gaertner, J Wilken, D Thompson, R Fish, A Ramos, ... Proceedings of the National Academy of Sciences 101 (47), 16460-16465, 2004 | 194 | 2004 |
| Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots Z Shulman, SJ Cohen, B Roediger, V Kalchenko, R Jain, V Grabovsky, ... Nature immunology 13 (1), 67-76, 2012 | 190 | 2012 |
| A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage. I Fisch, RE Kontermann, R Finnern, O Hartley, AS Soler-Gonzalez, ... Proceedings of the National Academy of Sciences 93 (15), 7761-7766, 1996 | 169 | 1996 |
| NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation L Serrander, V Jaquet, K Bedard, O Plastre, O Hartley, S Arnaudeau, ... Biochimie 89 (9), 1159-1167, 2007 | 164 | 2007 |
| Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide H Gaertner, F Cerini, JM Escola, G Kuenzi, A Melotti, R Offord, ... Proceedings of the National Academy of Sciences 105 (46), 17706-17711, 2008 | 158 | 2008 |
| Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab GJ Beyer, M Miederer, S Vranješ-Đurić, JJ Čomor, G Künzi, O Hartley, ... European journal of nuclear medicine and molecular imaging 31, 547-554, 2004 | 156 | 2004 |
| Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs VS Torre, AJ Marozsan, JL Albright, KR Collins, O Hartley, RE Offord, ... Journal of Virology 74 (10), 4868-4876, 2000 | 115 | 2000 |
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES C Pastore, GR Picchio, F Galimi, R Fish, O Hartley, RE Offord, DE Mosier Antimicrobial agents and chemotherapy 47 (2), 509-517, 2003 | 109 | 2003 |
| PSC-RANTES Blocks R5 Human Immunodeficiency Virus Infection of Langerhans Cells Isolated from Individuals with a Variety of CCR5 Diplotypes T Kawamura, SE Bruce, A Abraha, M Sugaya, O Hartley, RE Offord, ... Journal of virology 78 (14), 7602-7609, 2004 | 95 | 2004 |
| The biological effectiveness of antiproton irradiation MH Holzscheiter, N Bassler, N Agazaryan, G Beyer, E Blackmore, ... Radiotherapy and Oncology 81 (3), 233-242, 2006 | 93 | 2006 |
| Targeting chemokine receptors in HIV: a status report SE Kuhmann, O Hartley Annu. Rev. Pharmacol. Toxicol. 48, 425-461, 2008 | 88 | 2008 |
| An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity K Dorgham, A Ghadiri, P Hermand, M Rodero, L Poupel, M Iga, O Hartley, ... Journal of leukocyte biology 86 (4), 903-911, 2009 | 87 | 2009 |
| Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge RS Veazey, B Ling, LC Green, EP Ribka, JD Lifson, M Piatak Jr, ... The Journal of infectious diseases 199 (10), 1525-1527, 2009 | 86 | 2009 |
| Donor-and ligand-dependent differences in CC chemokine receptor 5 reexpression R Sabbe, GR Picchio, C Pastore, O Chaloin, O Hartley, R Offord, ... Journal of virology 75 (2), 661-671, 2001 | 83 | 2001 |
